SCHEMBL19126830

SCHEMBL19126830

O=Cc1ccncc1-c1ccc(Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 1/20 0.44
XDH P47989 1/20 0.39
CDC25B P30305 1/20 0.39
RPS6KA3 P51812 1/20 0.39
GCGR P47871 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38
MAPK14 Q16539 1/20 0.38
CSNK2A1 P68400 1/20 0.38
HIPK2 Q9H2X6 1/20 0.38
ERN1 O75460 2/20 0.38
CCNC P24863 2/20 0.38
CDK8 P49336 2/20 0.38
HSD17B10 Q99714 1/20 0.38
LIMK1 P53667 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11379135 0.82 SLC22A12 (0.46) SLC22A12RPS6KA3NPC1RAB9ASMN1; SMN2
SCHEMBL2556296 0.82 SLC22A12 (0.44) SLC22A12RPS6KA3SMN1; SMN2ALDH1A1ERN1
SCHEMBL11383161 0.81 CCNC (0.46) SLC22A12RPS6KA3SMN1; SMN2ALDH1A1ERN1
SCHEMBL15652488 0.81 SLC22A12 (0.48) SLC22A12RPS6KA3ALDH1A1ERN1CCNC
SCHEMBL29681568 0.81 CCNT1 (0.42) ERN1CCNCCDK8
SCHEMBL4294149 0.81 TDP1 (0.48) XDHCDC25BSMN1; SMN2KDM4EALDH1A1
SCHEMBL6824324 0.79 CACNA1B (0.40) XDHRPS6KA3ALDH1A1ERN1CCNC
SCHEMBL30479910 0.78 SLC22A12 (0.49) SLC22A12RPS6KA3NPC1RAB9ASMN1; SMN2
SCHEMBL2559873 0.77 MKNK1 (0.51) SLC22A12ERN1CCNCCDK8
SCHEMBL28279885 0.77 RPS6KA3 (0.63) SLC22A12CDC25BRPS6KA3GCGRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10654878-B2 Compounds of phosphinanes and azaphosphinanes, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2020-05-19 US disclosed
US-20190031693-A1 COMPOUNDS OF PHOSPHINANES AND AZAPHOSPHINANES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2019-01-31 US disclosed
US-10138260-B2 Compounds of phosphinanes and azaphosphinanes, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2018-11-27 US disclosed
EP-3271368-B1 NOVEL PHOSPHINANE AND AZAPHOSPHINANE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2018-10-31 EP disclosed
CN-108495857-A New phospha cyclohexane class compound and azepine phospha cyclohexane class compound, their preparation method and the Pharmaceutical composition comprising them 法国施维雅药厂 2018-09-04 CN disclosed
EP-3271368-A1 NOVEL PHOSPHINANE AND AZAPHOSPHINANE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Les Laboratoires Servier (FR) 2018-01-24 EP disclosed
US-20180016288-A1 COMPOUNDS OF PHOSPHINANES AND AZAPHOSPHINANES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2018-01-18 US disclosed
WO-2017121969-A1 NOVEL PHOSPHINANE AND AZAPHOSPHINANE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2017-07-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10654878-B2 Compounds of phosphinanes and azaphosphinanes, a process for their preparation and pharmaceutical compositions containing them TK1, AK1, PHKA1 SLC22A12 3542/4885XDH 1074/4885CDC25B 725/4885
US-10138260-B2 Compounds of phosphinanes and azaphosphinanes, a process for their preparation and pharmaceutical compositions containing them TK1, AK1, PHKA1 SLC22A12 3542/4885XDH 1074/4885CDC25B 725/4885
US-20180016288-A1 COMPOUNDS OF PHOSPHINANES AND AZAPHOSPHINANES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TK1, AK1, PHKA1 SLC22A12 3542/4885XDH 1074/4885CDC25B 725/4885
US-20190031693-A1 COMPOUNDS OF PHOSPHINANES AND AZAPHOSPHINANES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AK1, TK1, PHKA1 SLC22A12 3735/4885XDH 949/4885CDC25B 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.